# Telmisartan and Losartan in Hypertensive IGT

> **NCT00407862** · PHASE4 · COMPLETED · sponsor: **Medical University of Graz** · enrollment: 24 (—)

## Conditions studied

- Hypertension
- Impaired Glucose Tolerance

## Interventions

- **DRUG:** Telmisartan 80 mg
- **DRUG:** Losartan 50 mg

## Key facts

- **NCT ID:** NCT00407862
- **Lead sponsor:** Medical University of Graz
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** —
- **Final completion:** 2006-06
- **Target enrollment:** 24 (—)
- **Last updated:** 2006-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00407862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00407862, "Telmisartan and Losartan in Hypertensive IGT". Retrieved via MORVS 2026-10-17 from https://api.morvs.ai/clinical/NCT00407862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*